Nathan Fischel

@Dafna Capital Management Llc

Latest period2024 - Q3

Reported2mo 5d ago

Managed Assets$423.312M

Total holdings84

Assets growth rate1.14%

Assets growth rate (2-Q avg)-1.79%

Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Dafna Capital Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 84 positions.

Assets under management

The assets under management (AUM) of Dafna Capital Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 423.312M in assets, with a quarterly growth rate of 1.14% and a 2-quarter average growth rate of -1.79%. The portfolio is managed by Nathan Fischel, and others.

Portfolio holdings

Current New Position Increased Decreased Exited

Investment	Portfolio %	Reported Value	Recent Activity
AQSTAquestive Therapeutics Inc Recent Activity Increased 11.24%	0.7%	$2.936M 589,561 shares@ $4.99 avg price	Increased 11.24%
MLYSMineralys Therapeutics Inc Recent Activity Increased 23.11%	0.42%	$1.774M 146,500 shares@ $12.11 avg price	Increased 23.11%
AUTLAutolus Therapeutics Plc Recent Activity Increased 40.39%	0.42%	$1.767M 486,667 shares@ $3.63 avg price	Increased 40.39%
ITOSIteos Therapeutics Inc Recent Activity Increased 11.94%	0.39%	$1.65M 161,584 shares@ $10.22 avg price	Increased 11.94%
GPCRStructure Therapeutics Inc Recent Activity Increased 580%	0.36%	$1.492M 34,000 shares@ $43.89 avg price	Increased 580%
IMVTImmunovant Inc Recent Activity Increased 8.52%	0.36%	$1.482M 51,996 shares@ $28.52 avg price	Increased 8.52%
GOSSGossamer Bio Inc Recent Activity Increased 0.71%	0.34%	$1.4M 1.419M shares@ $0.99 avg price	Increased 0.71%
PYPDPolypid Ltd Recent Activity Increased 66.9%	0.26%	$1.061M 308,497 shares@ $3.45 avg price	Increased 66.9%
NVRONevro Corp Recent Activity Increased 35.72%	0.06%	$212,420 38,000 shares@ $5.59 avg price	Increased 35.72%